-->

Advanced Cancer Treatment

"Global Access to the Most Promising Advanced Cancer Treatment, Therapies & Clinical Trials."

Chat with experts now
Advanced cancer treatment

“At CancerFax, we are dedicated to facilitating access to advanced cancer treatment, ensuring patients receive care that is not only clinically effective but also financially accessible.”

We specialize in identifying and connecting patients with the most promising treatment options globally, including access to cutting-edge clinical trials and therapies like gene therapy, CAR T Cell therapy, TIL therapy, and advanced cancer cell therapies that may not yet be available elsewhere.

We stand by our promise: We do not rest until our patients achieve complete remission. With personalized care plans, expert medical guidance, and strong collaborations with leading hospitals and research centers worldwide, we fight alongside you.

Whether you’re exploring innovative treatment options or seeking a second opinion, CancerFax is your trusted partner, guiding you with compassion and expertise. Because for us, remission isn’t just an aspiration — it’s our commitment.

Your fight is our mission.

Survivor Stories

Cancer Survivor Stories

We love our users because they love us. Check out some of the love they’ve sent our way

I am Andreea Alexandra Milca, a name that may sound like a simple list of words but which hides behind it a whole world of experiences, struggles, and victories. I have been battling various forms of this disease since the age of 23, from triple-negative breast cancer to osteosarcoma and other tumors. Each diagnosis was a painful blow, but at the same time, a challenge that I accepted with determination. The discovery of the TP53 mutation and Li-Fraumeni syndrome gave me a deeper understanding of my vulnerability, but also of the importance of genetic testing in the oncological patient's journey. I understood that prevention and early detection can make the difference between life and death. Out of a desire to change things, to give hope to others, to help other patients, I founded the Sănătatea Viitorului association.

Andreea Alexandra Milca

Multiple Cancer Survivor, Romania

Yiyi, T-cell lymphoblastic lymphoma with central nervous system involvement and cytomegalovirus infection. After being diagnosed with T-cell lymphoblastic lymphoma at another hospital, Yiyi experienced several central relapses. She received multiple rounds of high-dose methotrexate and repeated intrathecal injections but did not achieve remission. When she was admitted to one of the best hematology hospitals in Beijing, China. Professor Yonghong ZHANG's team thoroughly reviewed her previous treatments and determined that her symptoms did not align with a central relapse. Further tests revealed that Yiyi had a concurrent cytomegalovirus infection, leading to a diagnosis of cytomegalovirus encephalitis. Following antiviral treatment, the abnormal cells in her central nervous system disappeared, and Yiyi's condition improved quickly. Her full remission, which has lasted, was the result of successful follow-up treatments. Yiyi, who enjoys singing and dancing, is now able to perform on stage again.

YiYi

T-cell lymphoblastic lymphoma with central nervous system involvement and cytomegalovirus infection

"I uneventfully went out of the transplant ward after more than 20 days. At that time, I was very optimistic, but I was really afraid that I had severe intestinal rejection after I went out of the warehouse. My attending doctor is the best doctor I've ever met in any hospital. In the hospital, I called her when I was uncomfortable, and she would come over and gently ask, "Baby, what's wrong with you?" I stayed in the hospital for so long with a positive mood and mentality thanks to the help of the doctor. She would answer my questions when I was not feeling well after I came home. Thanks to the CancerFax and GHG medical team for saving my life and healing my physical and mental ailments."

Lu

Myelodysplastic syndrome (MDS)

"Although the diagnosis of this disease was unexpected, my family and I promptly accepted it and initiated anti-tumor treatment, which represented a significant transition for me. I underwent a challenging course of treatment, involving immunotherapy, targeted therapies, antibody-based drugs, hematopoietic stem cell transplants, CAR-T therapy, and other potential options. However, despite these efforts, the tumor load remained unaltered. Unfortunately, my doctor informed me that there were no further promising therapies available in Russia at that time. Thanks to the CancerFax and GHG hospital team for ensuring I get the best possible treatment and care. I am fully fit and fine now."

Alina

Diffuse Large B-cell Lymphoma

Who are we?

"At CancerFax, we connect patients with advanced cancers and rare diseases to groundbreaking cell and gene therapy, including CAR T-cell therapy, TIL therapy and access to leading global clinical trials."

Our Story: Inspired by Love, Driven by Hope

Our Story

CancerFax was founded in memory of Asha Di, whose courageous battle with cancer inspires us to connect patients worldwide to cutting-edge therapies and a future of hope.

Our Vision

“Our vision is to lead the way in revolutionizing cancer treatment facilitation, ensuring every individual’s access to customized, comprehensive, and compassionate care."

Our Mission

"Through unwavering commitment, innovation, and a compassionate spirit, we aspire to redefine the cancer treatment landscape, offering hope, healing, and a brighter future for all those touched by cancer.”

Global partnerships

CancerFax proudly partners with leading hospitals, researchers, and biotech companies worldwide, ensuring patients gain access to the latest cancer treatments, innovative therapies, and groundbreaking clinical trials across multiple continents.

24x7 patient support

CancerFax offers 24x7 dedicated patient support, guiding individuals through every step of their treatment journey with personalized assistance, timely information, and compassionate care, no matter where they are in the world.

What do we offer?

Clinical trials

Clinical trials are research studies that evaluate new medical treatments, therapies, or devices in humans, ensuring their safety and effectiveness before approval for widespread use in healthcare practices.

Check details on

Cancer Clinical Trials

CAR T-Cell Therapy

CAR T-cell therapy is a groundbreaking cancer treatment that engineers a patient’s T-cells to target and destroy cancer cells, offering new hope for blood cancers and showing promise in solid tumors.

Check details on

CAR T-Cell Therapy

Gene Therapy

Gene therapy is a new frontier of medicine that involves treating or preventing diseases by altering the genetic material of an individual. This technique includes introducing, removing, or altering genetic material in the cells of an individual. Correcting defective genes or providing new genes through this technique consequently corrects the very basis of genetic disorders and diseases.

Check details on

Gene Therapy
Cancer treatment in India

Stem Cell Therapy

Much attention is now focused on stem cell therapy, the revolutionary line of treatment that involves the exploitation of the rich potential of stem cells in restoring damaged tissues and organs.

Check details on

Stem Cell Therapy

Gamma Delta T-Cell Therapy

Gamma delta T-cell therapy is the new frontier of cancer therapy and capitalizes on novel features of gamma delta T-cells, a unique subset of immune system T-cells. This is a therapy in which gamma delta T-cells from a patient or donor are isolated and expanded, then reinfused into patients to target and destroy cancer cells.

Check details on

Gamma Delta T-Cell Therapy
Cancer treatment in south korea

TIL Therapy

TIL therapy represents a sophisticated kind of immunotherapy that induces a patient's immune cells to fight against cancer. TILs are immune cells that naturally migrate into a tumor. The laboratory expands and activates TILs from the patient's tumor before reinfusing them back into the patient.

Check details on

TIL Therapy

Why Choose CancerFax?

CancerFax offers global access to cutting-edge cancer treatments, personalized patient support, partnerships with top hospitals and researchers, and a compassionate approach, ensuring patients receive the best care and latest therapies worldwide.

  • 15+ years of global experience
  • Ties with 100+ leading hospitals worldwide
  • Personalized treatment matching
  • Quick access to breakthrough therapies
  • Confidential, ethical, and compassionate service
Advanced cancer treatment with Cancerfax

Frequently Asked Questions

What are some advanced treatment options available for cancer?

Advanced cancer treatment options include:

  • Immunotherapy: This treatment uses the body’s immune system to fight cancer cells. It can be highly effective in certain cancers by boosting the immune response against cancer cells.

  • Targeted Therapy: This involves drugs that specifically target genetic mutations or abnormalities within cancer cells, minimizing damage to healthy cells.

  • Precision Medicine: By analyzing a patient’s genetic makeup and tumor characteristics, doctors can tailor treatments for specific cancer types, leading to more effective outcomes.

  • CAR T-cell Therapy: This innovative therapy involves genetically modifying a patient’s T-cells to recognize and attack cancer cells, particularly in blood cancers like leukemia, multiple myeloma, and lymphoma.

Accessing advanced cancer treatments involves several steps:

  • CancerFax: Send us your medical reports on email or WhatsApp and our medical team will guide you with best available advanced cancer treatment options.

  • Consultation with Oncologist: Patients should discuss advanced treatment options with their oncologist, who can provide information on available therapies and suitability for individual cases.

  • Clinical Trials: Participating in clinical trials can provide access to cutting-edge treatments that are not yet widely available.

  • Health Insurance Coverage: Patients should check with their health insurance provider to understand coverage for advanced treatments and associated costs.

  • Referral to Specialized Centers: Referral to specialized cancer centers or hospitals known for advanced cancer care can ensure access to a wider range of treatment options.

  • Patient Advocacy Groups: These groups can provide resources, support, and information on accessing advanced treatments and navigating the healthcare system effectively. Join our Facebook group, Conquering cancer.

CAR T-cell therapy is a revolutionary form of immunotherapy where a patient’s T-cells are genetically engineered to recognize and destroy cancer cells. This personalized treatment has shown remarkable success, particularly in blood cancers like leukemia, lymphoma, and multiple myeloma. It offers new hope for patients who have not responded to traditional therapies, marking a major advancement in cancer care.

You can access clinical trials by consulting your oncologist, searching online trial databases, or contacting specialized platforms like CancerFax. We help match patients with suitable clinical trials worldwide, guide them through eligibility checks, documentation, and enrollment processes, and ensure a smoother journey toward innovative treatments that may not yet be widely available but offer promising new options.

CancerFax connects patients with leading hospitals, research centers, and clinical trials across the globe. We assess your medical condition, recommend the best treatment options abroad, assist with hospital selection, travel arrangements, and documentation. Our personalized guidance ensures that you access the most advanced therapies, expert doctors, and world-class care, making your international treatment journey smooth and stress-free.

Cell and gene therapies are generally safe when administered by experienced medical teams within regulated clinical settings. These therapies undergo rigorous testing in clinical trials to ensure safety and effectiveness. While side effects like immune reactions may occur, strict monitoring and advanced medical protocols help manage risks, offering many patients powerful new options for conditions previously considered untreatable.

Check Full FAQ's

From Our Authors

Read the latest news, approvals, breakthrough therapies, and technology in cancer treatment.

Neoadjuvant and adjuvant pembrolizumab is approved by the USFDA for resectable locally advanced head and neck squamous cell carcinoma
Susan Hau
Neoadjuvant and adjuvant pembrolizumab is approved by the USFDA for resectable locally advanced head and neck squamous cell carcinoma

On June 12, 2025, the FDA approved pembrolizumab for both neoadjuvant and adjuvant use in adults with resectable locally advanced head and neck squamous cell carcinoma (HNSCC), based on strong outcomes from the KEYNOTE‑689 trial. Patients receiving pembrolizumab before and after surgery showed significant tumor shrinkage and improved disease‑free survival. This landmark decision marks a new standard of care, enabling immunotherapy to be integrated into multimodal treatment strategies for operable head and neck cancer.

Susan Hau June 19, 2025
Mitomycin intravesical solution is approved by the USFDA for recurrent low-grade intermediate-risk non-muscle invasive bladder cancer
Nishant Mittal (PhD)
Mitomycin intravesical solution is approved by the USFDA for recurrent low-grade intermediate-risk non-muscle invasive bladder cancer

On June 12, 2025, the FDA approved mitomycin intravesical solution (brand name Zusduri, formerly UGN‑102) as the first non‑surgical, chemoablative treatment for recurrent low‑grade, intermediate‑risk non‑muscle‑invasive bladder cancer (NMIBC), based on robust results from the phase 3 ENVISION trial. With a 78% complete response rate at three months and sustained remission in nearly 80% at 12 months, this six-week catheter‑delivered therapy marks a significant shift in bladder cancer management.

Nishant Mittal (PhD) June 19, 2025
Taletrectinib is approved by the USFDA for ROS1-positive non-small cell lung cancer
Susan Hau
Taletrectinib is approved by the USFDA for ROS1-positive non-small cell lung cancer

On June 11, 2025, the FDA approved taletrectinib (brand name Ibtrozi) for adults with locally advanced or metastatic ROS1‑positive non‑small cell lung cancer. Decision was based on the TRUST‑I and TRUST‑II trials demonstrating high objective response rates: about 89% in TKI‑naïve patients and 56% in those with prior ROS1 TKIs, alongside durable responses and strong intracranial activity.

Susan Hau June 18, 2025
Darolutamide is approved by the USFDA for metastatic castration-sensitive prostate cancer
Nishant Mittal (PhD)
Darolutamide is approved by the USFDA for metastatic castration-sensitive prostate cancer

On June 3, 2025, the FDA approved darolutamide (brand name Nubeqa) for the treatment of adult patients with metastatic castration-sensitive prostate cancer (mCSPC), with or without chemotherapy. This approval was granted following the Phase III ARANOTE trial, which showed that darolutamide plus androgen deprivation therapy cut the risk of radiographic progression or death by 46% compared to ADT alone.

Nishant Mittal (PhD) June 18, 2025
Check Latest Articles And News On Cancer

Everything you need to know about
different types of cancer

Cancer Types

Breast Cancer

Lung Cancer

Oral Cancer

Thyroid Cancer

Blood Cancer

Access Advanced Cancer Treatment with CancerFax

CancerFax is your trusted partner in accessing advanced cancer treatments abroad. We specialize in connecting patients with the latest breakthroughs, including CAR T-cell therapy, gene therapy for cancer, and cutting-edge cell therapy for cancer. Whether you’re searching for the best hospitals for cancer treatment or exploring new clinical trials for cancer, CancerFax offers personalized guidance every step of the way.

Our global network includes top hospitals, research centers, and biotech innovators, ensuring patients gain quick and reliable access to global cancer treatments. We help you find suitable cancer clinical trials, match your case with emerging therapies, and assist with travel, appointments, and medical documentation. With CancerFax, accessing personalized cancer treatment support becomes simple, compassionate, and stress-free.

Through our partnerships, we provide opportunities to participate in the latest cancer therapies, offering hope for conditions previously considered untreatable. Treatments like CAR T-cell therapy and gene therapy for cancer have already transformed lives, particularly for those facing advanced or resistant cancers. We also offer expert insights into cancer immunotherapy treatments and cell therapies that are changing the future of oncology.

Our 24×7 patient support ensures you are never alone. From consultation to treatment abroad, our team is with you at every stage, making your international care journey seamless. If you’re wondering about CAR T-cell therapy cost abroad or how to access cancer clinical trials, CancerFax provides clear, trusted information tailored to your needs.

Start your journey towards hope and healing with CancerFax — your bridge to the world’s most advanced therapies for cancer.

At CancerFax, we provide end-to-end concierge services for cancer patients, ensuring access to the most advanced treatments and expert care worldwide.  Our mission is to guide you through every step of your journey—from second opinions and personalized cancer treatment plans to cutting-edge therapies like CAR T-cell therapy, gene therapy, and T-cell immunotherapy.

We specialize in connecting patients with leading cancer hospitals in India, China, and the USA, offering FDA-approved treatments, clinical trial recruitment, and travel support for international patients. Whether you need CAR T-cell therapy for glioblastoma, neuroblastoma, or leukemia; gene therapy for thalassemia and sickle cell anemia; or TIL immunotherapy, our team collaborates with top oncologists and research centers to deliver hope and results. With online consultations from top cancer specialists, personalized T-cell therapies, and access to global clinical trials, we don’t rest until you achieve complete remission and a better quality of life. Trust CancerFax—where innovation meets compassionate care.

Why Choose China for Advanced Cancer Treatment?

For foreign patients seeking affordable cancer treatment, China has emerged as a leading destination, offering world-class care at competitive costs. The best cancer hospitals in China, such as Peking Union Medical College Hospital and Fudan University Shanghai Cancer Center, are renowned for their cutting-edge technology and top oncology specialists in China.

Advanced Therapies at Lower Costs

Many international patients search for “cancer treatment cost in China” because it’s significantly cheaper than in Western countries. China excels in proton therapy, immunotherapy for cancer, CAR-T cell therapy, and targeted therapy, making it a hub for medical tourism in China. Additionally, some hospitals integrate traditional Chinese medicine for cancer with modern treatments for holistic care.

Specialized Cancer Treatments

Whether you need lung cancer treatment, liver cancer specialists, breast cancer hospitals, stomach cancer treatment, or pancreatic cancer treatment, China’s top-tier facilities provide personalized care. Many hospitals also offer English-speaking doctors in China, ensuring smooth communication for international patients.

Seamless Medical Travel Experience

Navigating medical visas for China cancer treatment is straightforward, and hospitals provide international patient services to assist with travel, accommodation, and appointments. Before traveling, patients often look for “how to travel to China for medical treatment” and “cancer treatment success stories China” to make informed decisions.

For those comparing options, searches like “China vs India vs Thailand cancer treatment” highlight China’s strengths in affordability and technology. Cities like Beijing, Shanghai, and Guangzhou lead in clinical trials for cancer, offering innovative solutions.

At CancerFax.com, we connect patients with the best cancer hospitals in China, ensuring access to advanced, cost-effective care. Explore your options today and take the first step toward world-class treatment.

Most visited links: Advanced Cancer Treatment| Overview of CAR T-Cell Therapy |  CAR T-Cell Therapy in India |  CAR-T Cell therapy in China |  CAR T-Cell Therapy for Glioblastoma |  CAR T-Cell Therapy for Neuroblastoma |  CAR T-Cell Therapy for Chronic Lymphocytic Leukemia |  CAR T-Cell Therapy for Non-Small Cell Lung Cancer |  CAR T-Cell Therapy for Gastric Cancer |  CAR T-Cell Therapy in Autoimmune Disorders |  Overview of Gene Therapy |  Gene Therapy for Thalassemia |  Gene Therapy for Sickle Cell Anemia |  Gene Therapy in China |  FDA Approval for Gene Therapy in Metachromatic Leukodystrophy |  Explore Ongoing Cancer Clinical Trials |  Clinical Trial Recruitment for BALL CAR T-Cell Therapy |  Clinical Trial for BCMA/TACI-Positive Multiple Myeloma |  Online Consultation with Top Cancer Doctors in the USA |  Personalized T-Cell Therapies for Hematological Malignancies |  Tumor-Infiltrating Lymphocyte (TIL) Immunotherapy in India |  T-Cell and NK Cell Therapy in India |  Cancer Treatment in the USA for Foreigners | Cost of cancer treatment

We Are Online! Chat With Us!
Scan the code